To develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment. HTML TitleFuture MSDescriptionTo develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment.StatusActivePIProfessor Siddharthan ChandranEdinburgh Imaging CollaboratorProfessor Adam WaldmanDiseaseMultiple Sclerosis (MS)Facility / resourceEIF QMRIEIF RIEProject typeMulti-centre longitudinal cohort studyFundingAnne Rowling Regenerative Neurology Clinic (ARRNC) Relevant links15 Feb 22. FutureMS-2 imaging begins19 Nov 21. FutureMS-2 launched28 Sep 17. MS studies This article was published on 2024-08-22
HTML TitleFuture MSDescriptionTo develop predictive tools for focal neuroinflammatory disease activity over 12-months based on baseline clinical, laboratory, & genomic assessment.StatusActivePIProfessor Siddharthan ChandranEdinburgh Imaging CollaboratorProfessor Adam WaldmanDiseaseMultiple Sclerosis (MS)Facility / resourceEIF QMRIEIF RIEProject typeMulti-centre longitudinal cohort studyFundingAnne Rowling Regenerative Neurology Clinic (ARRNC) Relevant links15 Feb 22. FutureMS-2 imaging begins19 Nov 21. FutureMS-2 launched28 Sep 17. MS studies
